• About Us
    • List of Regulators
    • News Websites
  • What We Do
    • Downloads
  • Mission
  • Vision
  • Contact Us
  • Terms of use
  • Privacy Policy
  • Disclaimer
Investadvocate
  • Home
  • Business News
    • Capital Market
    • Money Market
    • Fraud & Scandals
    • Results & Dividends
  • Updates
  • Investors Bite
  • World News
  • Trending
  • Over-the-Counter Beat
  • Q & A Session

All Posts in "OPINION/EDITORIAL"

Cost of a Healthy Diet Rises in September

Cost of a Healthy Diet Rises in September

November 1, 2024/CSL Research Recent data from the National Bureau of Statistics (NBS) shows that…
by InvestAdvocate — November 1, 2024 in OPINION/EDITORIAL 0
Asia’s Economies Can Embrace Services to Boost Growth and Productivity

Asia’s Economies Can Embrace Services to Boost Growth and Productivity

(Credit: JohnnyGreig/iStock by Getty Images) November 1, 2024/IMFBlog (Credit: JohnnyGreig/iStock by Getty Images) By Chikako…
by InvestAdvocate — November 1, 2024 in OPINION/EDITORIAL 0
2023 IGR Across States & FCT Up 26.03% Y/Y

2023 IGR Across States & FCT Up 26.03% Y/Y

October 31, 2024/CSL Research The National Bureau of Statistics (NBS) recently released its 2023 Internally…
by InvestAdvocate — October 31, 2024 in OPINION/EDITORIAL 0

Posts pagination

Previous 1 … 295 296 297 … 1,707 Next
WEEKLY TOP GAINERS
COYOPENING PRICECLOSING PRICE% CHG
UPDCREIT 10.65 14.20+33.33%
FBNH959.95120.50+25.59%
UNILEVER124.00147.95+19.31%
CADBURY   57.00  67.50+18.42%
AXAMANS    11.20   13.20+17.86%
WEEKLY TOP LOSERS
COYOPENING PRICECLOSING PRICE% CHG
MECURE85.4562.40-26.97%
ROYALEX   1.48  1.29-12.84%
TRIPLGE    3.89   3.41-12.34%
SUNUASR    4.00     3.60-10.00%
BUAFOODS939.00845.10-10.00%

Source: NGX as at July 24, 2026

APO NEWSROOM

Follow Investadvocate on Twitter

Tweets by @investadvocate

Regulators Links

 

NGX

SEC

CBN

EFCC

CSCS

NDIC

MORE

 

TV Stations

 

CNN

AlJazeera

TVC News

AIT

Channels TV

BBC

CNBC

News Websites

 

Yahoo! News 

Premier League

The Will 

Proshare

Huhuonline

Financial Times 

More

 

opan

 

 

© 2026 Investadvocate ·